Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Seminars in Immunopathology
Published in: Seminars in Immunopathology 2/2011

01-03-2011 | Review

Regulatory T cells in lung transplantation—an emerging concept

Authors: David C. Neujahr, Christian P. Larsen

Published in: Seminars in Immunopathology | Issue 2/2011

Login to get access

Abstract

Lung transplantation represents an option for patients with a variety of end-stage lung diseases. While surgical advances have led to improvements in short-term survival, long-term survival is limited by chronic rejection termed bronchiolitis obliterans syndrome (BOS). A growing body of work is devoted to determining why some patients develop BOS. One avenue of interest that has emerged recently is the role that regulatory T cells (Tregs) may have in protection from BOS. In this review, we will discuss the evidence that Tregs are relevant to outcomes following transplant. We will discuss the relevant animal models, in vitro assays, and human observational studies that support a role for Tregs. We will also explore the interplay between injurious T cells such as Th17 cells and Tregs as well as the effect that additional cell types and chemokines have on the balance between inflammation and regulation. Finally, we will review emerging therapies which may harness the ability of Tregs to lessen the effects of BOS.
Literature
1.
Christie JD, Edwards LB, Aurora P et al (2009) The Registry of the International Society for Heart and Lung Transplantation: Twenty-sixth Official Adult Lung and Heart-Lung Transplantation Report-2009. J Heart Lung Transplant 28:1031–1049PubMedCrossRef
2.
Zheng XX, Sanchez-Fueyo A, Domenig C, Strom TB (2003) The balance of deletion and regulation in allograft tolerance. Immunol Rev 196:75–84PubMedCrossRef
3.
Lerut J, Sanchez-Fueyo A (2006) An appraisal of tolerance in liver transplantation. Am J Transplant 6:1774–1780PubMedCrossRef
4.
Martinez-Llordella M, Puig-Pey I, Orlando G et al (2007) Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant 7:309–319PubMedCrossRef
5.
Bennett CL, Christie J, Ramsdell F et al (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21PubMedCrossRef
6.
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057–1061PubMedCrossRef
7.
Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+ CD25+ regulatory T cells. Nat Immunol 4:330–336PubMedCrossRef
8.
von Boehmer H (2005) Mechanisms of suppression by suppressor T cells. Nat Immunol 6:338–344CrossRef
9.
Carrier Y, Yuan J, Kuchroo VK, Weiner HL (2007) Th3 cells in peripheral tolerance. I. Induction of Foxp3-positive regulatory T cells by Th3 cells derived from TGF-beta T cell-transgenic mice. J Immunol 178:179–185PubMed
10.
11.
Haldar P, Pavord ID, Shaw DE et al (2008) Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 178:218–224PubMedCrossRef
12.
Molet S, Hamid Q, Davoine F et al (2001) IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol 108:430–438PubMedCrossRef
13.
Wakashin H, Hirose K, Maezawa Y et al (2008) IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 178:1023–1032PubMedCrossRef
14.
Hartl D, Koller B, Mehlhorn AT et al (2007) Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol 119:1258–1266PubMedCrossRef
15.
Kearley J, Barker JE, Robinson DS, Lloyd CM (2005) Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+ CD25+ regulatory T cells is interleukin 10 dependent. J Exp Med 202:1539–1547PubMedCrossRef
16.
Kearley J, Robinson DS, Lloyd CM (2008) CD4+ CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J Allergy Clin Immunol 122:617.e6–624.e6CrossRef
17.
18.
Rubenfeld GD, Caldwell E, Peabody E et al (2005) Incidence and outcomes of acute lung injury. N Engl J Med 353:1685–1693PubMedCrossRef
19.
D'Alessio FR, Tsushima K, Aggarwal NR et al (2009) CD4+ CD25+ Foxp3+ Tregs resolve experimental lung injury in mice and are present in humans with acute lung injury. J Clin Invest 119:2898–2913PubMedCrossRef
20.
Haque MA, Mizobuchi T, Yasufuku K et al (2002) Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 169:1542–1549PubMed
21.
Yasufuku K, Heidler KM, O'Donnell PW et al (2001) Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 25:26–34PubMed
22.
Yasufuku K, Heidler KM, Woods KA et al (2002) Prevention of bronchiolitis obliterans in rat lung allografts by type V collagen-induced oral tolerance. Transplantation 73:500–505PubMedCrossRef
23.
Lauer-Fields JL, Sritharan T, Stack MS, Nagase H, Fields GB (2003) Selective hydrolysis of triple-helical substrates by matrix metalloproteinase-2 and -9. J Biol Chem 278:18140–18145PubMedCrossRef
24.
Beeh KM, Beier J, Kornmann O, Micke P, Buhl R (2001) Sputum levels of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1, and their ratio correlate with airway obstruction in lung transplant recipients: relation to tumor necrosis factor-alpha and interleukin-10. J Heart Lung Transplant 20:1144–1151PubMedCrossRef
25.
Taghavi S, Krenn K, Jaksch P, Klepetko W, Aharinejad S (2005) Broncho-alveolar lavage matrix metalloproteases as a sensitive measure of bronchiolitis obliterans. Am J Transplant 5:1548–1552PubMedCrossRef
26.
Hubner RH, Meffert S, Mundt U et al (2005) Matrix metalloproteinase-9 in bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 25:494–501PubMedCrossRef
27.
Soccal PM, Gasche Y, Miniati DN et al (2004) Matrix metalloproteinase inhibition decreases ischemia-reperfusion injury after lung transplantation. Am J Transplant 4:41–50PubMedCrossRef
28.
Bharat A, Fields RC, Trulock EP, Patterson GA, Mohanakumar T (2006) Induction of IL-10 suppressors in lung transplant patients by CD4+ 25+ regulatory T cells through CTLA-4 signaling. J Immunol 177:5631–5638PubMed
29.
Stassen M, Fondel S, Bopp T et al (2004) Human CD25+ regulatory T cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34:1303–1311PubMedCrossRef
30.
Bharat A, Fields RC, Steward N, Trulock EP, Patterson GA, Mohanakumar T (2006) CD4+ 25+ regulatory T cells limit Th1-autoimmunity by inducing IL-10 producing T cells following human lung transplantation. Am J Transplant 6:1799–1808PubMedCrossRef
31.
Mizobuchi T, Yasufuku K, Zheng Y et al (2003) Differential expression of Smad7 transcripts identifies the CD4+ CD45RChigh regulatory T cells that mediate type V collagen-induced tolerance to lung allografts. J Immunol 171:1140–1147PubMed
32.
Jiang S, Lechler RI, He XS, Huang JF (2006) Regulatory T cells and transplantation tolerance. Hum Immunol 67:765–776PubMedCrossRef
33.
Yamada Y, Sekine Y, Yoshida S et al (2009) Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 183:237–245PubMedCrossRef
34.
Burlingham WJ, Love RB, Jankowska-Gan E et al (2007) IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 117:3498–3506PubMedCrossRef
35.
Valencia X, Stephens G, Goldbach-Mansky R, Wilson M, Shevach EM, Lipsky PE (2006) TNF downmodulates the function of human CD4+ CD25hi T-regulatory cells. Blood 108:253–261PubMedCrossRef
36.
O’Sullivan BJ, Thomas HE, Pai S et al (2006) IL-1 beta breaks tolerance through expansion of CD25+ effector T cells. J Immunol 176:7278–7287PubMed
37.
Bettelli E, Carrier Y, Gao W et al (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–238PubMedCrossRef
38.
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006) TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24:179–189PubMedCrossRef
39.
Mangan PR, Harrington LE, O'Quinn DB et al (2006) Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441:231–234PubMedCrossRef
40.
Deknuydt F, Bioley G, Valmori D, Ayyoub M (2009) IL-1beta and IL-2 convert human Treg into T(H)17 cells. Clin Immunol 131:298–307PubMedCrossRef
41.
Osorio F, LeibundGut-Landmann S, Lochner M et al (2008) DC activated via dectin-1 convert Treg into IL-17 producers. Eur J Immunol 38:3274–3281PubMedCrossRef
42.
Koenen HJ, Smeets RL, Vink PM, van Rijssen E, Boots AM, Joosten I (2008) Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112:2340–2352PubMedCrossRef
43.
Jaffar Z, Ferrini ME, Girtsman TA, Roberts K (2009) Antigen-specific Treg regulate Th17-mediated lung neutrophilic inflammation, B-cell recruitment and polymeric IgA and IgM levels in the airways. Eur J Immunol 39:3307–3314PubMedCrossRef
44.
Studer SM, George MP, Zhu X et al (2008) CD28 down-regulation on CD4 T cells is a marker for graft dysfunction in lung transplant recipients. Am J Respir Crit Care Med 178:765–773PubMedCrossRef
45.
Tai X, Cowan M, Feigenbaum L, Singer A (2005) CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 6:152–162PubMedCrossRef
46.
Meloni F, Vitulo P, Bianco AM et al (2004) Regulatory CD4+ CD25+ T cells in the peripheral blood of lung transplant recipients: correlation with transplant outcome. Transplantation 77:762–766PubMedCrossRef
47.
Zeiser R, Nguyen VH, Beilhack A et al (2006) Inhibition of CD4+ CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production. Blood 108:390–399PubMedCrossRef
48.
Botturi K, Lacoeuille Y, Thomas P, Boniface S, Reynaud-Gaubert M, Magnan A (2008) CTLA-4-mediated regulatory phenotype of T-cells in tolerant lung recipients. Eur Respir J 31:1167–1176PubMedCrossRef
49.
Hwu P, Du MX, Lapointe R, Do M, Taylor MW, Young HA (2000) Indoleamine 2, 3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation. J Immunol 164:3596–3599PubMed
50.
Meloni F, Giuliano S, Solari N et al (2009) Indoleamine 2, 3-dioxygenase in lung allograft tolerance. J Heart Lung Transplant 28:1185–1192PubMedCrossRef
51.
Gregson AL, Hoji A, Saggar R et al (2008) Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation 85:1056–1059PubMedCrossRef
52.
Neujahr DC, Cardona AC, Ulukpo O et al (2009) Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation 88:521–527PubMedCrossRef
53.
Bestard O, Cruzado JM, Rama I et al (2008) Presence of FoxP3+ regulatory T Cells predicts outcome of subclinical rejection of renal allografts. J Am Soc Nephrol 19:2020–2026PubMedCrossRef
54.
Muthukumar T, Dadhania D, Ding R et al (2005) Messenger RNA for FOXP3 in the urine of renal-allograft recipients. N Engl J Med 353:2342–2351PubMedCrossRef
55.
Gavin MA, Torgerson TR, Houston E et al (2006) Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci USA 103:6659–6664PubMedCrossRef
56.
Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE (2007) Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol 37:129–138PubMedCrossRef
57.
Janson PC, Winerdal ME, Marits P, Thorn M, Ohlsson R, Winqvist O (2008) FOXP3 promoter demethylation reveals the committed Treg population in humans. PLoS ONE 3(2):e1612PubMedCrossRef
58.
Mamessier E, Lorec AM, Thomas P, Badier M, Magnan A, Reynaud-Gaubert M (2007) T regulatory cells in stable posttransplant bronchiolitis obliterans syndrome. Transplantation 84:908–916PubMedCrossRef
59.
Belperio JA, Keane MP, Burdick MD et al (2003) Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 171:4844–4852PubMed
60.
Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM (2006) Intratumoral CD4+ CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 107:3639–3646PubMedCrossRef
61.
Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10:942–949PubMedCrossRef
62.
Maeda A, Schwarz A, Kernebeck K et al (2005) Intravenous infusion of syngeneic apoptotic cells by photopheresis induces antigen-specific regulatory T cells. J Immunol 174:5968–5976PubMed
63.
Maeda A, Schwarz A, Bullinger A, Morita A, Peritt D, Schwarz T (2008) Experimental extracorporeal photopheresis inhibits the sensitization and effector phases of contact hypersensitivity via two mechanisms: generation of IL-10 and induction of regulatory T cells. J Immunol 181:5956–5962PubMed
64.
Bladon J, Taylor P (2002) Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo. J Clin Apher 17:177–182PubMedCrossRef
65.
Rao V, Saunes M, Jorstad S, Moen T (2009) Cutaneous T cell lymphoma and graft-versus-host disease: a comparison of in vivo effects of extracorporeal photochemotherapy on Foxp3+ regulatory T cells. Clin Immunol 133:303–313PubMedCrossRef
66.
Schmitt S, Johnson TS, Karakhanova S, Naher H, Mahnke K, Enk AH (2009) Extracorporeal photophoresis augments function of CD4+ CD25+ FoxP3+ regulatory T cells by triggering adenosine production. Transplantation 88:411–416PubMedCrossRef
67.
Morrell MR, Despotis GJ, Lublin DM, Patterson GA, Trulock EP, Hachem RR (2009) The efficacy of photopheresis for bronchiolitis obliterans syndrome after lung transplantation. J Heart Lung Transplant 29:424–431PubMedCrossRef
68.
Meloni F, Cascina A, Miserere S, Perotti C, Vitulo P, Fietta AM (2007) Peripheral CD4(+)CD25(+) TREG cell counts and the response to extracorporeal photopheresis in lung transplant recipients. Transplant Proc 39:213–217PubMedCrossRef
69.
Bluestone JA (2005) CTLA-4Ig is finally making it: a personal perspective. Am J Transplant 5:423–424PubMedCrossRef
70.
71.
Tang Q, Henriksen KJ, Boden EK et al (2003) Cutting edge: CD28 controls peripheral homeostasis of CD4+ CD25+ regulatory T cells. J Immunol 171:3348–3352PubMed
72.
Okazaki M, Sugimoto S, Lai J et al (2009) Costimulatory blockade-mediated lung allograft acceptance is abrogated by overexpression of Bcl-2 in the recipient. Transplant Proc 41:385–387PubMedCrossRef
73.
Bluestone JA, Liu W, Yabu JM et al (2008) The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant 8:2086–2096PubMedCrossRef
74.
Vincenti F, Charpentier B, Vanrenterghem Y et al (2010) A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 10:535–546PubMedCrossRef
75.
Dao Nguyen X, Robinson DS (2004) Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 114:296–301PubMedCrossRef
76.
Karagiannidis C, Akdis M, Holopainen P et al (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114:1425–1433PubMedCrossRef
77.
Peek EJ, Richards DF, Faith A et al (2005) Interleukin-10-secreting "regulatory" T cells induced by glucocorticoids and beta2-agonists. Am J Respir Cell Mol Biol 33:105–111PubMedCrossRef
78.
Xystrakis E, Kusumakar S, Boswell S et al (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116:146–155PubMedCrossRef
79.
Yeh SH, Chuang H, Lin LW et al (2009) Regular Tai Chi Chuan exercise improves T cell helper function of patients with type 2 diabetes mellitus with an increase in T-bet transcription factor and IL-12 production. Br J Sports Med 43:845–850PubMedCrossRef
80.
Lowder T, Dugger K, Deshane J, Estell K, Schwiebert LM (2010) Repeated bouts of aerobic exercise enhance regulatory T cell responses in a murine asthma model. Brain Behav Immun 24:153–159PubMedCrossRef
81.
Bergeron A, Belle A, Chevret S et al (2007) Combined inhaled steroids and bronchodilatators in obstructive airway disease after allogeneic stem cell transplantation. Bone Marrow Transplant 39:547–553PubMedCrossRef
82.
De Soyza A, Fisher AJ, Small T, Corris PA (2001) Inhaled corticosteroids and the treatment of lymphocytic bronchiolitis following lung transplantation. Am J Respir Crit Care Med 164:1209–1212PubMed
Metadata
Title
Regulatory T cells in lung transplantation—an emerging concept
Authors
David C. Neujahr
Christian P. Larsen
Publication date
01-03-2011
Publisher
Springer-Verlag
Published in
Seminars in Immunopathology / Issue 2/2011
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-011-0253-0

Other articles of this Issue 2/2011

Seminars in Immunopathology 2/2011 Go to the issue

Introduction

Transplantation and tolerance

Review

Role of Th17 cells and IL-17 in lung transplant rejection

Review

The role of innate immunity in donor organ procurement

Review

Inflammation and transplantation tolerance

Review

Assessment of kidney organ quality and prediction of outcome at time of transplantation

Review

Lung transplantation: infection, inflammation, and the microbiome
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits